Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q3 2016 call → NOWe need to determine if management conveys that outsiders are currently underweighting something the company has already done, and points to a concrete, already-completed/operating piece of the business whose contribution is still ahead. Let's analyze the transcript. Key points: - Management discusses various operational metrics, property performance, refinancing, acquisitions. - They mention the Hyde Resort and Residences acquisition (condo hotel) in Hollywood, Florida, expected to close in Q1 2017. That's not yet closed, so not already in place. - They mention refinancing, which is done, but that's not a business piece with future contribution. - They mention the Whitehall hotel in Houston, which is ramping up. They say "the Whitehall ramp up continues to move at a slower pace than we hope" and "we have seen some positive momentum at the property since early September" and "we can lead the business outpacing what we have previously achieved at the Crowne Plaza giving credence to the convergence strategy and appeal of a new independent boutique product offering." They also mention it's currently the number three hotel in Houston. This is an already-operating property, but its contribution is still ramping. However, is management saying outsiders are underweighting it? They mention the market struggles, but not necessarily a recognition gap about the company's perception. - They mention the Savannah renovation, which is underway, not complete. - They mention the sale of Hampton hotel, but that's a disposition. - They mention the preferred stock offering and redemption of notes, which is a capital structure change. - They mention the impact of hurricane Matthew, which is a negative. - In the Q&A, an analyst (Ryan Vardeman) asks about the Hollywood property and the dividend, and also mentions that the stock is below $5 while NAV is around $14.3 per share. The analyst asks: "Is there anything outside the normal course that you think we could do over the next couple of years to narrow that gap?" Drew Sims responds: "We are looking at some things, we are looking at some things now and I just, I can't comment on right at this moment but Ryan, but we will keep you in the loop as soon as we can." That's not a concrete already-in-place thing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.